Mary E. Janes
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Pluripotent Stem Cells Research
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- CRISPR and Genetic Engineering
Papers in
-
- Epigenetics and DNA Methylation 4
- Pluripotent Stem Cells Research 4
- Congenital heart defects research 3
- Genomics and Chromatin Dynamics 2
- CRISPR and Genetic Engineering 2
- Surgery 2
- Pancreatic function and diabetes 2
- Co-authors
- Kathy Knezevic (5 shared papers)Edouard G. Stanley (3 shared papers)Andrew G. Elefanty (3 shared papers)Suzanne J. Micallef (2 shared papers)Richard P. Davis (1 shared paper)Berthold Göttgens (6 shared papers)John E. Pimanda (5 shared papers)George Follows (4 shared papers)
- Journals
- Blood (3 papers)Stem Cell Research (2 papers)PLoS ONE (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- AustraliaUnited KingdomItaly
In The Last Decade
Mary E. Janes
10 papers receiving 449 citations
Peers
Comparison fields: 5 of 47
- Hematology 71
- Molecular Biology 340
- Cell Biology 47
- Surgery 109
- Immunology 49
Countries citing papers authored by Mary E. Janes
This map shows the geographic impact of Mary E. Janes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Janes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Janes more than expected).
Fields of papers citing papers by Mary E. Janes
This network shows the impact of papers produced by Mary E. Janes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Janes. The network helps show where Mary E. Janes may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary E. Janes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 124 | |
| 2 | 2010 | 100 | |
| 3 | 2009 | 62 | |
| 4 | 2009 | 42 | |
| 5 | 2008 | 42 | |
| 6 | 2006 | 32 | |
| 7 | 2011 | 17 | |
| 8 | 2011 | 16 | |
| 9 | 2007 | 15 | |
| 10 | 2012 | 7 |
About Mary E. Janes
Mary E. Janes is a scholar working on Molecular Biology, Surgery, Cell Biology, Immunology and Public Health, Environmental and Occupational Health, having authored 10 papers that have together received 457 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Pluripotent Stem Cells Research (4 papers), Congenital heart defects research (3 papers), Genomics and Chromatin Dynamics (2 papers), Zebrafish Biomedical Research Applications (2 papers), Pancreatic function and diabetes (2 papers), CRISPR and Genetic Engineering (2 papers) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Hematology (71 citations), Molecular Biology (340 citations), Cell Biology (47 citations), Surgery (109 citations) and Immunology (49 citations). Mary E. Janes has collaborated with scholars based in Australia, United Kingdom and Italy. Frequent co-authors include Kathy Knezevic, Edouard G. Stanley, Andrew G. Elefanty, Suzanne J. Micallef, Richard P. Davis, Berthold Göttgens, John E. Pimanda, George Follows, Nicola K. Wilson and Sarah Kinston. Their work appears in journals such as Blood, Stem Cell Research, PLoS ONE, Arteriosclerosis Thrombosis and Vascular Biology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.